{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:25:40Z","timestamp":1740176740051,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100016253","name":"Atara Biotherapeutics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016253","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncol Ther"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40487-020-00131-3","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T12:03:19Z","timestamp":1602676999000},"page":"299-310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Qualitative Findings on the Impact of Disease in Epstein\u2013Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Patients, as Measured by EQ-5D, SF-36, and the FACT-LYM"],"prefix":"10.1007","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8763-9197","authenticated-orcid":false,"given":"Crystal","family":"Watson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie","family":"Barlev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason C.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhumi","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"issue":"4","key":"131_CR1","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1200\/JCO.1995.13.4.961","volume":"13","author":"V Leblond","year":"1995","unstructured":"Leblond V, Sutton L, Dorent R, et al. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol. 1995;13(4):961\u20138.","journal-title":"J Clin Oncol"},{"issue":"1","key":"131_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.critrevonc.2005.03.015","volume":"56","author":"AL Taylor","year":"2005","unstructured":"Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol. 2005;56(1):155\u201367.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"131_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11899-013-0162-5","volume":"8","author":"Z Al-Mansour","year":"2013","unstructured":"Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep. 2013;8(3):173\u201383.","journal-title":"Curr Hematol Malig Rep"},{"issue":"Suppl 4","key":"131_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/ajt.12104","volume":"13","author":"UD Allen","year":"2013","unstructured":"Allen UD, Preiksaitis JK. Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):107\u201320.","journal-title":"Am J Transplant"},{"issue":"1","key":"131_CR5","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1097\/TXD.0000000000000557","volume":"2","author":"ML Nijland","year":"2016","unstructured":"Nijland ML, Kersten MJ, Pals ST, Bemelman FJ, Ten Berge IJ. Epstein\u2013Barr virus-positive posttransplant lymphoproliferative disease after solid organ transplantation: pathogenesis, clinical manifestations, diagnosis, and management. Transplant Direct. 2016;2(1):e48.","journal-title":"Transplant Direct"},{"issue":"6","key":"131_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMra1702693","volume":"378","author":"D Dierickx","year":"2018","unstructured":"Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med. 2018;378(6):549\u201362.","journal-title":"N Engl J Med"},{"issue":"2","key":"131_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1034\/j.1399-3062.2001.003002070.x","volume":"3","author":"SM Cockfield","year":"2001","unstructured":"Cockfield SM. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis. 2001;3(2):70\u20138.","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"131_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1158\/1078-0432.CCR-0670-3","volume":"10","author":"MP Thompson","year":"2004","unstructured":"Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res. 2004;10(3):803\u201321.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"131_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ajh.21911","volume":"86","author":"SC Quinlan","year":"2011","unstructured":"Quinlan SC, Pfeiffer RM, Morton LM, Engels EA. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol. 2011;86(2):206\u20139.","journal-title":"Am J Hematol"},{"issue":"4","key":"131_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4103\/2229-3485.86879","volume":"2","author":"PR Deshpande","year":"2011","unstructured":"Deshpande PR, Rajan S, Sudeepthi BL, Abdul Nazir CP. Patient-reported outcomes: a new era in clinical research. Perspect Clin Res. 2011;2(4):137\u201344.","journal-title":"Perspect Clin Res"},{"key":"131_CR11","unstructured":"U.S. Food and Drug Administration (FDA). Patient-focused drug development: collecting comprehensive and representative input. [Draft guidance]. 2018. https:\/\/www.fdanews.com\/ext\/resources\/files\/2018\/06-12-18-DrugDevelopment.pdf. Accessed Oct 2019."},{"key":"131_CR12","unstructured":"U.S. Food and Drug Administration (FDA). Patient-focused drug development: methods to identify what is important to patients guidance for industry, Food and Drug Administration staff, and other stakeholders. [Draft guidance]. 2019. https:\/\/www.fda.gov\/media\/131230\/download. Accessed Oct 2019."},{"issue":"Suppl 7","key":"131_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/1469-0691.12534","volume":"20","author":"R San-Juan","year":"2014","unstructured":"San-Juan R, Comoli P, Caillard S, et al. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients. Clin Microbiol Infect. 2014;20(Suppl 7):109\u201318.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"131_CR14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1182\/blood.V106.11.750.750","volume":"106","author":"D Cella","year":"2005","unstructured":"Cella D, Webster K, Cashy J, et al. Development of a measure of health-related quality of life for non-Hodgkin's lymphoma clinical research: the functional assessment of cancer therapy-lymphoma (FACT-Lym). Blood. 2005;106(11):750. https:\/\/doi.org\/10.1182\/blood.V106.11.750.750.","journal-title":"Blood"},{"issue":"9","key":"131_CR15","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.3109\/10428194.2012.762977","volume":"54","author":"FJ Hlubocky","year":"2013","unstructured":"Hlubocky FJ, Webster K, Beaumont J, et al. A preliminary study of a health related quality of life assessment of priority symptoms in advanced lymphoma: the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy\u2014Lymphoma Symptom Index. Leuk Lymphoma. 2013;54(9):1942\u20136.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"131_CR16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570\u20139.","journal-title":"J Clin Oncol"},{"key":"131_CR17","doi-asserted-by":"publisher","unstructured":"Hlubocky F, Webster K, Cashy J, Beaumont J, Cella D. The development and validation of a measure of health-related quality of life for non-Hodgkin\u2019s lymphoma: the Functional Assessment of Cancer Therapy\u2014Lymphoma (FACT-Lym). Lymphoma. 2013;2013:147176. https:\/\/doi.org\/10.1155\/2013\/147176.","DOI":"10.1155\/2013\/147176"},{"issue":"3","key":"131_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1037\/1040-3590.7.3.238","volume":"7","author":"SN Haynes","year":"1995","unstructured":"Haynes SN, Richard DC, Kubany EW. Content validity in psychological assessment: a functional approach to concepts and methods. Psychol Assess. 1995;7(3):238\u201347.","journal-title":"Psychol Assess"},{"issue":"10","key":"131_CR19","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"6","key":"131_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"key":"131_CR21","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, Kline Leidy N, Martin ML, Molsen E, et al. Content validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluations: ISPOR PRO Good Research Practices Task Force Report: part 1\u2014 eliciting concepts for a new PRO instrument. Value Health. 2011;14:967\u201377.","journal-title":"Value Health"}],"container-title":["Oncology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40487-020-00131-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40487-020-00131-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40487-020-00131-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T01:49:56Z","timestamp":1634176196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40487-020-00131-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["131"],"URL":"https:\/\/doi.org\/10.1007\/s40487-020-00131-3","relation":{},"ISSN":["2366-1070","2366-1089"],"issn-type":[{"type":"print","value":"2366-1070"},{"type":"electronic","value":"2366-1089"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}